Carolina Hawranek

PhD and Research Coordinator in Pediatric Oncology. Co-researcher within the Swedish DIRECT-study and project lead on lung cancer screening development.

[Carolina Hawranek @hawranek]

Att prata om ärftlig cancerrisk kan kännas motigt och jätteviktigt. Samtidigt. Hur kan hälso- och sjukvården bättre samarbeta med patienter för att informera familjen om genetisk risk? https://t.co/Gg6t4DU7NM #scicomm #pressmeddelande #umeåuniversitet #cancer #genetik #prevention

[Carolina Hawranek @hawranek]

@japanisverige Ett helt fantastiskt program som borde vara en förebild för många andra länder. Multikulturell kompetens, fredsbevarande och ledarskapsutveckling i ett.

[Carolina Hawranek @hawranek]

Är höjden av forsknings-impact antal läsare eller vilka som läser? Blev iaf väldigt glad av att se min avhandling i Sveriges kanske främsta filosofiska tidsskrift Sans, där Lisbeth Sachs refererat bra och korrekt till våra data. https://t.co/Xxr0npc0bP #scicomm #impact

[Carolina Hawranek @hawranek]

@KendallSciWrite @Nature @rach_garr @AlisonRBentley What a fantastic theme issue - and so much valuable and important content. We'll definitely incorporate and spread this within our local community network at uni!

[Carolina Hawranek @hawranek]

När är information livsavgörande? Läs mitt reportage om riskinformation för ärftlig cancer i senaste numret av Onkologi Sverige. https://t.co/3fpWBxAVWi

[Carolina Hawranek @hawranek]

Nailed it. Thesis titled "Someone has to tell them - exploring hereditary cancer risk disclosure in Sweden" is officially published for public scrutiny: https://t.co/whzuR8eEuV #thesis #nailingceremony #cancer #oncogenetics #hereditaryrisk #prevention #riskdisclosure

[Carolina Hawranek @hawranek]

Sexual harassment as a factor in scientific excellence and economic output in research production. Finally we’re taking this diskussion to a new level. Thanks @Britt-Inger Keisu och @UCGC and @umeauniversitet

[Carolina Hawranek @hawranek]

Polygenic Risk Scores will NOT revolutionize clinical genetics or risk stratification. Clear conclusion by @clare__turnbull with stellar figures and impressive clarity. Best talk of the conference yet! #PrecisionMedicineEurope2022

[Carolina Hawranek @hawranek]

@genomicmedswe @clare_turnbull Absolutely excellent presentation. Impressive clarity and overview given by @clare__turnbull 💪🏼

[Carolina Hawranek @hawranek]

The Director of the Swedish Office for Life Sciences @JNordborg delivers a translational perspective on the needs and ambitions of a modernized healthcare and research infrastrukture in #precisionhealth in Sweden. #jInternMed #PrecisionMedicineEurope2022

[Genomic Medicine Sweden @genomicmedswe]

Great panel discussion #PrecisionMedicineEurope2022 reflecting around the importance of patient and public engagement, education both for healthcare profession and patients in medical genomics, cost coverage and increasing costs for interpretation.

[Carolina Hawranek @hawranek]

”Driving a paradigm change” in the UK is seeing familiar challenges - but also impressive solutions on a large scale through the @NHSuk - excellent overview by Sue Hill. ”Moving away from single-gene testing” in #precisionmedicineeurope2022 @JInternMed

[Carolina Hawranek @hawranek]

@EmmaTham @JInternMed Målen med mötet känns otroligt välformulerade och angelägna. Heja gärna om du ser mig @EmmaTham

[Carolina Hawranek @hawranek]

We need to ”hurry up a bit” says KI rector @ottersenolep about implementing research breakthroughs to patient benefit. The welcome adress also hightlights the importance of #prevention and #equity in the implementation of #precisionmedicineeurope2022 @JInternMed #karolinska

[Carolina Hawranek @hawranek]

@genomicmedswe @JInternMed @rosenquistbrand Great welcome and interesting programme - really happy to be here!

[Carolina Hawranek @hawranek]

On site at KI: Collaboration on #PrecisionMedicine between countries is the overall aim of ”Cutting-Edge Implementation of Precision Medicine in Europe”. Great vibe as the international research community can meet again thank’s to the JIM and @genomicmedswe

[Carolina Hawranek @hawranek]

We needed a baseline to compare with our patient outcomes. And found none. So we surveyed the public and now there is a baseline: Cancer Worry Distribution and Willingness to Undergo Colonoscopy at Three Levels of Hypothetical Cancer Risk-A Popu… https://t.co/6giu0qQW0Q

[Carolina Hawranek @hawranek]

Excellent wrap-up of a decade of GC evaluation in the US by Heather Zierhut and the FOCUS framework as well as Genetic Counselling Checklist. #ESHG2022

[Carolina Hawranek @hawranek]

Such an interesting morning session day 2 of #eshg2022 - genetic education best practices, power of communication and evidence-based evaluation. Thank you Professor @ClaraGaff @nicolagarde and Victoria Nembaware for great perspectives and insights!

[James Fasham @JamesFasham]

Wow, what an #ESHG2022 talk!

#CRISPR-Cas9 causes off target structural variants in zebrafish
NOT detected by short-read sequencing and ARE passed on to offspring.

Huge implications to studies and any possible future therapeutic editing

Paper is here:
https://t.co/ttHLW5bnG2